HOME >> BIOLOGY >> NEWS
Connecticut chemist receives award for cleaner air technology

William C. Pfefferle, of Precision Combustion Inc. in North Haven, Conn., was honored June 17 by the world's largest scientific society for developing technologies that reduce the emission of greenhouse gases. He received one of two 2003 Industrial Innovation Awards at the American Chemical Society's Northeast regional meeting in Saratoga Springs, N.Y.

Nicknamed the "father of catalytic combustion," Pfefferle invented the original catalytic combustor for gas turbine engines in the early 1970s. Gas turbines used to provide thrust for jet aircraft and generate electricity work by mixing fuel with compressed and heated air, which then burns and generates energy to turn the turbines. Unfortunately, nitrogen oxide gases, which contribute to global warming, are emitted during this process. Pfefferle has developed a process that uses a catalyst a substance used to speed up a chemical reaction to allow combustion without the significant formation of nitrogen oxides and carbon monoxide.

Pfefferle, who cofounded Precision Combustion in 1986, has dedicated his career to developing clean and efficient technologies for combustion engines. He has also invented the Microlith(r) catalytic reactor for automobiles and fuel processing and the RCL™ catalytic combustor for ground-power gas turbine machines.

Pfefferle received a bachelor's degree in chemical engineering from Drexel University and a doctorate in physical chemistry from the University of Pennsylvania. He holds 90 U.S. patents and has several pending.

The American Chemical Society's Industrial Innovation Awards recognize individuals and teams whose discoveries and inventions contribute to the commercial success of their companies and enhance our quality of life.


'"/>

Contact: Sharon Worthy
s_worthy@acs.org
202-872-4371
American Chemical Society
23-Jun-2003


Page: 1

Related biology news :

1. Nerac again named one of Connecticuts fastest growing technology companies
2. Michigan, Connecticut and Illinois chemists receive award for drug to combat antibiotic resistance
3. NOAA fisheries, Connecticut, New York Sea Grant Programs announce research grants: $3.5 million in sound research to address lobster die-offs
4. UT Southwestern biochemist honored with NIH Directors Pioneer Award
5. NJIT chemist speaks Aug. 25 about compound derived from pine tree
6. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
7. U of T research answers key question in biochemistry
8. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
9. Rutgers chemist uses NMR to elucidate protein-DNA interaction
10. New multidisciplinary research tops chemists meeting Aug. 22-26
11. Wisconsin chemists find a new chink in TBs armor

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Connecticut chemist receives award for cleaner air technology

(Date:5/21/2013)... shows that the nation,s land and water resources could ... up to 25 billion gallons of algae-based fuel a ... yearly needs. , The findings come from an in-depth ... to grow significant amounts of algae in large, specially ... May 7 issue of Environmental Science and Technology ...
(Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2
(Date:5/22/2013)...  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the ... LLP Microcap Conference, May 30, in New York, ... , CPA, Chief Financial Officer of Cleveland BioLabs, will ... at 1:30 p.m. Eastern Time.  A live and archived webcast ... page of the Cleveland BioLabs website at www.cbiolabs.com . ...
(Date:5/22/2013)... MN (PRWEB) May 22, 2013 ... Medical Supplies Pty Ltd are pleased to announce ... is the Australian and New Zealand distributor of DrugCheck® ... V8 Supercar Team participated in the Austin 400 May ... entered into an agreement that involves each car of ...
(Date:5/22/2013)... A recent study from researchers in Tasmania ... that those who took probiotics were able to run for ... showed that in extreme heat conditions, probiotics were able to ... acne treatment explains what this new discovery means for ... skin condition. , While researchers tote the benefits of ...
(Date:5/21/2013)... May 22, 2013 First patients ... of glycopyrronium bromide designed using Prosonix, particle engineering platform ... a portfolio of inhaled Respiratory Medicines by Design ... PSX1002 that will assess its effect on lung function ... patients with moderate to severe chronic obstructive pulmonary disease ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: